Plasma levels of main granulocyte components during cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 95, Issue 6, 1988, Pages 1014-1019

  Riegel, W ^a   Spillner, G ^a   Schlosser, V ^a   Horl, W H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; DILTIAZEM; DIPYRIDAMOLE; ELASTASE; LACTOFERRIN; MYELOPEROXIDASE; NIFEDIPINE;

ADULT; AGED; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; GRANULOCYTE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0023951783     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)35668-5     Document Type: Article

References (18)

1. Hörl WH Jochum M Heidland A Fritz H Release of granulocyte proteinases during hemodialysis Am J Nephrol 3 1983 213 217
2. Hörl WH Heidland A Evidence for the participation of granulocyte proteinases in intradialytic catabolism Clin Nephrol 21 1984 314 322
3. Hörl WH Schaefer RM Heidland A Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis Am J Nephrol 5 1985 320 326
4. Hörl WH Steinhauer HB Schollmeyer P Plasma levels of granulocyte elastase during hemodialysis. Effects of different dialyzer membranes Kidney Int 28 1985 791 796
5. Ivanovich P Chenoweth DE Schmidt R Symptoms and activation of granulocytes and complement with two dialysis membranes Kidney Int 24 1983 758 763
6. Chenoweth DE Cheung AK Henderson LW Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes Kidney Int 24 1983 764 769
7. Chenoweth DE Complement activation during hemodialysis: clinical observations, proposed mechanisms and theoretical implications Artif Organs 8 1984 281 287
8. Hakim RM Fearon DT Lazarus JM Biocompatibility of dialysis membranes: effects of chronic complement activation Kidney Int 26 1984 194 200
9. Chenoweth DE Cooper SW Hugli TE Stewart RW Blackstone EH Kirklin JW Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins N Engl J Med 304 1981 497 503
10. Neumann S Hennrich N Gunzer G Lang H Enzyme-linked immunoassay for human granulocyte elastase in complex with α-proteinase inhibitor Hörl WH Heidland A Proteases: potential role in health and disease 1984 Plenum Press New York 379 390
11. Hörl WH Riegel W Schollmeyer P Rautenberg W Neumann S Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers Clin Nephrol 25 1986 304 307
12. Hugli TE Chenoweth DE Biologically active peptides of complement: techniques and significance of C3a and C5a measurements Nakamura RM Dito WR Tucker ES Immunoassays: clinical laboratory techniques for the 1980s 1980 Alan R. Liss New York 443 460
13. Havemann K Gramse M Physiology and pathophysiology of neutral proteinases of human granulocytes Hörl WH Heidland A Proteinases: potential role in health and disease 1984 Plenum Press New York 1 20
14. Spitznagel IL Intracellular and extracellular degranulation of human polymorphonuclear azurophil and septic granules induced by immune complexes Havemann K Janoff A Neutral proteases of human polymorphonuclear leukocytes 1978 Urban & Schwarzenberg Baltimore 82 85
15. Olofsson T Olsson I Venge P Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia Scand J Haematol 18 1977 113 120
16. Ohlsson K Laurell CB The disappearance of enzyme-inhibitor complexes from the circulation of man Clin Sci Mol Med 51 1976 87 92
17. Fritz H Jochum M Duswald K-H Granulocyte proteinases as mediators of unspecific proteolysis in inflammation: a review Goldberg DM Werner M Selected topics in clinical enzymology 1984 Walter de Gruyter Berlin 305 328
18. Hörl M Sperling M Mayer J Hörl WH Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass operation Eur Surg Res 18 1986 69 79